Ligand validation:5FB9

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FB9_BTB_B_601	55%	66%	0.131	0.897	0.87	0.46	1	-	0	0	100%	1
5FB9_BTB_A_601	34%	62%	0.19	0.871	0.87	0.58	-	-	0	0	100%	1
5FBB_BTB_A_1001	78%	54%	0.092	0.933	0.95	0.85	-	-	0	0	100%	1
7QTB_BTB_A_408	70%	63%	0.137	0.955	1	0.42	1	-	0	0	100%	1
7QTA_BTB_B_408	47%	72%	0.172	0.911	0.84	0.27	1	-	0	0	100%	1
5O5D_BTB_B_504	100%	66%	0.02	0.995	0.94	0.38	2	-	0	0	100%	1
5O59_BTB_A_605	99%	76%	0.057	0.987	0.52	0.44	-	-	2	0	100%	1
2OB3_BTB_A_906	98%	13%	0.06	0.986	2.82	1.16	4	1	0	0	100%	1
9FZ6_BTB_C_902	98%	69%	0.07	0.989	0.83	0.37	-	-	1	0	100%	0.2
2OQL_BTB_B_701	95%	63%	0.066	0.969	0.66	0.75	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.